Eurofins Advinus is a leading R&D services company supporting the discovery and development of compounds across diverse industries, including Pharmaceuticals, Biologics, Agrochemicals, Nutraceuticals, and Cosmetics.
As part of Eurofins Scientific, a €6.95 billion international group of laboratories, Eurofins Advinus benefits from a global network delivering advanced analytical testing services to the pharmaceutical, food, environmental, and consumer goods industries, as well as to regulatory agencies worldwide.
Regulatory Toxicology Services through Our Partner, Adgyl Lifesciences
With over three decades of GLP experience, Eurofins Advinus offers a comprehensive portfolio of regulatory toxicology and safety assessment services through a trusted partner laboratory, Adgyl Lifesciences.
These services are conducted in full compliance with global regulatory standards to support clinical trials, IND submissions, and international product registrations. Through this collaboration, we deliver high-quality, GLP-compliant studies with scientific rigor and operational excellence.
Our safety assessment capabilities offered via Adgyl Lifesciences:
- Acute, sub-chronic, and chronic toxicology
- Reproductive and developmental toxicity
- Carcinogenicity and genotoxicity studies
- Juvenile toxicity and transgenic models
- SEND-compliant data management and digital pathology
All studies are carried out under AAALAC-accredited animal facilities and reviewed by Institutional Animal Ethics Committees (IAEC), aligned with IACUC standards.
Comprehensive IND-Enabling Support
For the pharmaceutical and biotech industries, Eurofins Advinus provides a full spectrum of IND-enabling services, including:
- Drug metabolism and pharmacokinetics (DMPK)
- Chemical process development
- Analytical research and development
- Long-term non-clinical toxicology (via Adgyl Lifesciences)
We also support regulatory submissions for other industries, such as Agrochemicals, Cosmetics, Nutraceuticals, and Industrial Chemicals, through tailored analytical, toxicology, and chemistry services.
Innovation-Driven Drug Discovery
Eurofins Advinus is among the pioneers in India’s drug discovery landscape, with a proven record of success in collaborative research. Our discovery chemistry programs have led to impactful partnerships with leading global organizations, including:
- Takeda
- Merck
- Johnson & Johnson
- Novartis
- Celgene
- Drugs for Neglected Diseases initiative (DNDi)
These collaborations reflect our ability to bring scientific depth, operational agility, and global regulatory alignment to every program we support.
